CDKN3 and glioma: Molecular and genetic analysis to explore the pathogenesis of gliomas and the clinical application of targeted therapy for each subtype of gliomas is also a current research hot spot where deletion of PTEN gene, deletion or mutation of cyclin-dependent kinase inhibitor protein, etc. are studied.